Practice Pearls

Medical experts discuss several topics pertaining to the evolving treatments in HR+/HER2- advanced breast cancer, including unmet needs and the integral role of pharmacists in patient care.

Pharmacy specialists discuss quality initiatives for myeloproliferative neoplasms, highlighting the importance of patient-specific, informative care in polycythemia vera, essential thrombocythemia, and myelofibrosis.

Experts in gynecologic oncology review the use of PARP inhibitors in ovarian cancer with a primary focus of these agents as a frontline maintenance strategy.

A panel of experts discuss several topics pertaining to best practices and the challenges in regard to prophylaxis in hemophilia A, including the role of prophylaxis, prophylactic therapy options, outpatient care factors, and economic considerations.

Madeline Camejo, PharmD, MS, Michael Epshteyn, PharmD, MSM, and Estela Trimino, PharmD, BCPS, provide insights into the best practices implemented within their institutions by health-system pharmacy to address challenges brought on by COVID-19 related to infection control, treatment, and vaccine rollout.